On ECHEMI
Home > Drugs > Anhu Welman Pharmaceut Icai Cd.ltd
Anhu Welman Pharmaceut Icai Cd.ltd
  • Founded in:

    1992-06-19
  • Country:

    China China
  • Address:

    No. 510, Wangjiang West Road, High-tech Zone, Hefei City, Anhui Province
  • Tax NO.:

    913401006103789162
  • Registered Funds:

    $3,041,030
  • Website:

  • Email:

Related Drugs
Propacetamol Hydrochloride
Name Description Content CAS NO. Registered Holders
Propacetamol

66532-85-2 11
Ropivacaine Mesylate Injection
The main component of this product is ropivacaine mesylate, chemical name is (S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinamide methanesulfonate Molecular formula: C17H26N2O.CH3SO3H Molecular weight: 370.51
Name Description Content CAS NO. Registered Holders
Ropivacaine mesylate

It may block the generation and conduction of nerve impulses by increasing the threshold of nerve action potential, delaying the spread of nerve impulses, and reducing the speed of action potential increase. The generation of anesthetic effect is related to the axial diameter, myelination and conduction velocity of nerve fibers.

More

It may block the generation and conduction of nerve impulses by increasing the threshold of nerve action potential, delaying the spread of nerve impulses, and reducing the speed of action potential increase. The generation of anesthetic effect is related to the axial diameter, myelination and conduction velocity of nerve fibers.

854056-07-8 8
Ropivacaine Mesylate Injection
The main component of this product is ropivacaine mesylate, chemical name is (S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinamide methanesulfonate Molecular formula: C17H26N2O.CH3SO3H Molecular weight: 370.51
Name Description Content CAS NO. Registered Holders
Ropivacaine mesylate

It may block the generation and conduction of nerve impulses by increasing the threshold of nerve action potential, delaying the spread of nerve impulses, and reducing the speed of action potential increase. The generation of anesthetic effect is related to the axial diameter, myelination and conduction velocity of nerve fibers.

More

It may block the generation and conduction of nerve impulses by increasing the threshold of nerve action potential, delaying the spread of nerve impulses, and reducing the speed of action potential increase. The generation of anesthetic effect is related to the axial diameter, myelination and conduction velocity of nerve fibers.

854056-07-8 8
Ceftriaxone Sodium for Injection
The main ingredient of this product is ceftriaxone sodium.
Name Description Content CAS NO. Registered Holders
Cephalothin sodium

This product is a first-generation cephalosporin with a broad antibacterial spectrum and strong activity against Gram-positive bacteria. Penicillinase-producing and non-penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococcus, Streptococcus pyogenes, Streptococcus pneumoniae, Group B hemolytic Streptococcus, Streptococcus viridans, Staphylococcus epidermidis, Corynebacterium diphtheriae, and Bacillus anthracis are all quite sensitive to this product. Enterococci, methicillin-resistant Staphylococcus, Listeria, and Nocardia are resistant. Haemophilus influenzae, Neisseria meningitidis, Moraxella catarrhalis, and Neisseria gonorrhoeae are highly sensitive to this product. Some strains of Escherichia coli, Klebsiella, Salmonella, Shigella, and Proteus are moderately sensitive to this product, while most of the other Gram-negative rods are resistant. Gram-positive anaerobic bacteria are sensitive to this product, and Bacteroides fragilis is resistant to this product. This product mainly inhibits the synthesis of bacterial cell walls.

More

This product is a first-generation cephalosporin with a broad antibacterial spectrum and strong activity against Gram-positive bacteria. Penicillinase-producing and non-penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococcus, Streptococcus pyogenes, Streptococcus pneumoniae, Group B hemolytic Streptococcus, Streptococcus viridans, Staphylococcus epidermidis, Corynebacterium diphtheriae, and Bacillus anthracis are all quite sensitive to this product. Enterococci, methicillin-resistant Staphylococcus, Listeria, and Nocardia are resistant. Haemophilus influenzae, Neisseria meningitidis, Moraxella catarrhalis, and Neisseria gonorrhoeae are highly sensitive to this product. Some strains of Escherichia coli, Klebsiella, Salmonella, Shigella, and Proteus are moderately sensitive to this product, while most of the other Gram-negative rods are resistant. Gram-positive anaerobic bacteria are sensitive to this product, and Bacteroides fragilis is resistant to this product. This product mainly inhibits the synthesis of bacterial cell walls.

58-71-9 18
Azithromycin for injection
Main ingredients: The main ingredient of this product is azithromycin. Its chemical name is (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta;-D-xyl-pyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Structural formula: (see azithromycin dry suspension) Molecular formula: C38H72N2O12 Molecular weight: 749
Name Description Content CAS NO. Registered Holders
Azithromycin

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

More

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

83905-01-5 39
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.